Toll-like receptors in atherosclerosis

Area of Science:

• Cardiovascular Science
• Immunology
• Molecular Biology

Background:

• Atherosclerosis, a primary cause of cardiovascular disease (CVD), is fundamentally driven by inflammatory processes.
• Toll-like receptors (TLRs) are increasingly recognized as critical regulators of the atherosclerotic disease cascade.
• TLRs detect conserved molecular patterns, initiating intracellular signaling pathways that influence inflammation.

Purpose of the Study:

• To review novel findings concerning Toll-like receptor (TLR) signaling in the context of atherosclerosis.
• To highlight the distinct roles of individual TLRs in the atherosclerotic disease process.
• To discuss emerging research on endosomal TLRs and future directions in TLR-focused atherosclerosis research.

Main Methods:

• Literature review of recent scientific publications on TLRs and atherosclerosis.
• Analysis of studies investigating TLR activation, downstream signaling pathways (MyD88, TRIF), and cytokine production.
• Synthesis of findings related to both cell surface and endosomal TLRs.

Main Results:

• TLRs play a complex and crucial role in orchestrating inflammation during atherosclerosis.
• Distinct TLRs exhibit varied contributions to the atherosclerotic process.
• TLR activation leads to the production of both pro-inflammatory and anti-inflammatory cytokines via MyD88 and TRIF pathways.

Conclusions:

• TLR signaling is a central mechanism in the pathogenesis of atherosclerosis.
• Understanding individual TLR functions and endosomal TLRs offers new therapeutic avenues for CVD.
• Further research into TLRs is essential for developing targeted anti-atherosclerotic strategies.